+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Personalized Cell & Gene Therapies Market by Therapy Type, Patient Type, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Personalized Cell & Gene Therapies Market by Therapy Type, Patient Type, Therapeutic Area, End User - Global Forecast to 2030- Product Image
Sale

Personalized Cell & Gene Therapies Market by Therapy Type, Patient Type, Therapeutic Area, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055132
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The personalized cell and gene therapies market is evolving rapidly, reshaping the pharmaceutical landscape as innovation, partnership, and technology integration become vital for sustained growth and competitive advantage.

Market Snapshot: Personalized Cell & Gene Therapies Market

The Personalized Cell & Gene Therapies Market grew from USD 13.88 billion in 2024 to USD 16.30 billion in 2025. It is expected to continue growing at a CAGR of 20.01%, reaching USD 41.49 billion by 2030. Stakeholders across biopharmaceuticals, healthcare providers, and research organizations are leveraging the latest genomic and cell-processing technologies to drive cost-effective, high-impact treatments. Strategic collaborations and the implementation of new regulatory pathways are accelerating the adoption of these therapies. As manufacturing capabilities and digital monitoring tools advance, the potential for broad patient access increases across diverse regional markets.

Scope & Segmentation

This report delivers a comprehensive analysis, categorizing the market into critical segments and geographies. Insights include market trends, emerging players, technological advancements, and operational challenges that shape the competitive environment.

  • Therapy Type: Cell therapy and gene therapy programs, ranging from autologous to allogeneic products and advanced vector-based interventions.
  • Patient Type: Adults, geriatrics, and pediatrics, each with unique safety, efficacy, and ethical considerations for clinical development.
  • Therapeutic Area: Applications spanning cardiology, hematology, immunology, metabolic diseases, neurology, oncology, and rare diseases.
  • End User: Engagement from biopharmaceutical companies, hospitals and clinics, as well as research institutions driving innovation and commercialization.
  • Regions: Significant activity in the Americas (US, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the UK, Germany, France, Italy, and more), and Asia-Pacific (notably China, India, Japan, Australia, and key Southeast Asian markets).
  • Key Technologies: Advanced gene editing (CRISPR-Cas systems, base editing), viral/non-viral delivery methods, modular and automated biomanufacturing, and digital patient engagement solutions.
  • Leading Companies Evaluated: Market leaders include Adaptimmune Limited, Allogene Therapeutics, Amgen Inc., Beam Therapeutics Inc., bluebird bio, Inc., Bristol-Myers Squibb Company, CRISPR Therapeutics AG, Editas Medicine, Inc., Genentech, Inc., Novartis AG, and others.

Key Takeaways for Decision-Makers

  • Bespoke cell and gene therapies are providing personalized solutions across a spectrum of disease areas, expanding clinical possibilities for previously untreatable conditions.
  • Cross-functional partnerships among biopharmaceutical innovators, academic institutions, and contract developers are facilitating end-to-end integration and efficient knowledge transfer.
  • Investment in scalable, modular manufacturing and robust quality systems is essential to ensure production consistency, regulatory compliance, and accelerated go-to-market timelines.
  • Digital health integration—spanning real-world data capture, remote patient monitoring, and decentralized clinical trials—enhances outcome measurement and supports payer negotiations.
  • Increasing demand for value-based reimbursement models highlights the importance of robust real-world evidence and health economics research during commercialization planning.
  • Organizations that adopt agile R&D approaches and invest in advanced platforms are best positioned to secure leadership in the evolving personalized therapies market.

Tariff Impact: Navigating US Tariff Dynamics

Upcoming US tariffs on essential raw materials, single-use consumables, and specialized reagents are exerting upward pressure on manufacturing costs and logistics. Companies have reacted by diversifying their supplier base, developing domestic sourcing, and establishing material reserves, in turn maintaining operational continuity and patient access. Policy advocacy and procurement partnerships with academic centers are shaping novel strategies to absorb or bypass tariff-related hurdles, emphasizing supply chain resilience as a key differentiator.

Methodology & Data Sources

The findings in this report are built on primary interviews with industry experts, academic researchers, and regulatory advisors, supported by ongoing secondary research of scientific publications, company reports, and policy documents. Rigorous triangulation ensures coherence and reliability across data sources.

Why This Report Matters

  • Enables strategic planning and investment decisions with actionable insights across market segments, geographies, and competitor activity in the personalized cell and gene therapies space.
  • Delivers operational intelligence on navigating complex supply chains, technological shifts, and emerging regulatory frameworks.
  • Supports risk mitigation by outlining key industry trends, competitive benchmarking, and forward-looking opportunities tailored for senior leadership.

Conclusion

The personalized cell and gene therapies market is set to deliver impactful patient outcomes while reshaping global biopharmaceutical strategies. Decision-makers equipped with detailed segment insights and stakeholder analysis will drive sustainable growth in this rapidly advancing field.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Personalized Cell & Gene Therapies Market, by Therapy Type
8.1. Introduction
8.2. Cell Therapy
8.3. Gene Therapy
9. Personalized Cell & Gene Therapies Market, by Patient Type
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Personalized Cell & Gene Therapies Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiology
10.3. Hematology
10.4. Immunology
10.5. Metabolic Diseases
10.6. Neurology
10.7. Oncology
10.8. Rare Diseases
11. Personalized Cell & Gene Therapies Market, by End User
11.1. Introduction
11.2. Biopharmaceutical Companies
11.3. Hospitals & Clinics
11.4. Research Institutions
12. Americas Personalized Cell & Gene Therapies Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Personalized Cell & Gene Therapies Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Personalized Cell & Gene Therapies Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Adaptimmune Limited
15.3.2. Allogene Therapeutics
15.3.3. Amgen Inc.
15.3.4. Arcellx, Inc.
15.3.5. Beam Therapeutics Inc.
15.3.6. BioCell Innovations
15.3.7. bluebird bio, Inc.
15.3.8. Bristol-Myers Squibb Company
15.3.9. Caribou Biosciences, Inc.
15.3.10. Celyad Oncology SA
15.3.11. CRISPR Therapeutics AG
15.3.12. Editas Medicine, Inc.
15.3.13. Fate Therapeutics, Inc.
15.3.14. Genentech, Inc.
15.3.15. Gilead Sciences, Inc.
15.3.16. Intellia Therapeutics, Inc.
15.3.17. Lonza Group Ltd.
15.3.18. Miltenyi Biomedicine GmbH
15.3.19. Novartis AG
15.3.20. Sana Biotechnology, Inc.
15.3.21. Sangamo Therapeutics, Inc.
15.3.22. Sarepta Therapeutics, Inc
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PERSONALIZED CELL & GENE THERAPIES MARKET MULTI-CURRENCY
FIGURE 2. PERSONALIZED CELL & GENE THERAPIES MARKET MULTI-LANGUAGE
FIGURE 3. PERSONALIZED CELL & GENE THERAPIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PERSONALIZED CELL & GENE THERAPIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PERSONALIZED CELL & GENE THERAPIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PERSONALIZED CELL & GENE THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 36. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 38. CANADA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 42. MEXICO PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 59. UNITED KINGDOM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 61. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 62. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. GERMANY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 67. FRANCE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 69. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 71. RUSSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 75. ITALY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 77. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. SPAIN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 81. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 83. UNITED ARAB EMIRATES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 87. SAUDI ARABIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 91. SOUTH AFRICA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 93. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. DENMARK PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 97. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 98. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 101. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 102. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 103. QATAR PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 105. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. FINLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 109. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 111. SWEDEN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 119. EGYPT PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 121. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 122. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 123. TURKEY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 129. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 131. NORWAY PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 133. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 134. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 135. POLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 146. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 148. CHINA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 150. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 152. INDIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. JAPAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 154. JAPAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. JAPAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 156. JAPAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. THAILAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 170. THAILAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. THAILAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 172. THAILAND PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. MALAYSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 178. MALAYSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. MALAYSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. MALAYSIA PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN PERSONALIZED CELL & GENE THERAPIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. PERSONALIZED CELL & GENE THERAPIES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 194. PERSONALIZED CELL & GENE THERAPIES MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Personalized Cell & Gene Therapies market report include:
  • Adaptimmune Limited
  • Allogene Therapeutics
  • Amgen Inc.
  • Arcellx, Inc.
  • Beam Therapeutics Inc.
  • BioCell Innovations
  • bluebird bio, Inc.
  • Bristol-Myers Squibb Company
  • Caribou Biosciences, Inc.
  • Celyad Oncology SA
  • CRISPR Therapeutics AG
  • Editas Medicine, Inc.
  • Fate Therapeutics, Inc.
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • Intellia Therapeutics, Inc.
  • Lonza Group Ltd.
  • Miltenyi Biomedicine GmbH
  • Novartis AG
  • Sana Biotechnology, Inc.
  • Sangamo Therapeutics, Inc.
  • Sarepta Therapeutics, Inc

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 41.49 Billion
Compound Annual Growth Rate20.0%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type, Nanotechnology Type, Application, End User - Global Forecast to 2030 - Product Image

Personalized Nanotechnology for Cell & Gene Therapies Market by Therapy Type, Nanotechnology Type, Application, End User - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Cell & Gene Therapy Manufacturing Services Market by Service Type, Technology Type, Therapeutic Area, Application, End-User - Global Forecast to 2030 - Product Image

Cell & Gene Therapy Manufacturing Services Market by Service Type, Technology Type, Therapeutic Area, Application, End-User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Cell Sheet-based Gene Therapy Market - A Global and Regional Analysis: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Cell Sheet-based Gene Therapy Market - A Global and Regional Analysis: Focus on Technology Type, Cell-sheet Type, Source Type, Application Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • 128 Pages
  • Global
From
Gene Therapy Market Outlook to 2029 - Product Image

Gene Therapy Market Outlook to 2029

  • Report
  • 83 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.